ArticleFrontiers in pharmacology2020

Identification of FPR3 as a Unique Biomarker for Targeted Therapy in the Immune Microenvironment of Breast Cancer.

Jian Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.